select a format

Single User License
USD 750 INR 48090
Site License
USD 1500 INR 96180
Corporate User License
USD 2250 INR 144270

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Metabolon, Inc.-Product Pipeline Analysis, 2016 Update

Metabolon, Inc.-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME17188PD
  • |
  • Pages: 39
  • |
  • July 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Metabolon, Inc. (Metabolon) is a biotechnology company that develops clinical diagnostic tests for healthcare markets. The company offers products ,which include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a blood test performed for detecting early-stage insulin resistance. Metabolon also offers biomarker services. The company collaborates with research institutions, pharmaceutical, nutrition, agricultural and consumer goods companies for its research activities. It has presence in the UK and the US. Metabolon is headquartered in Durham, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Metabolon, Inc.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Metabolon, Inc. Company Snapshot 6

Metabolon, Inc. Company Overview 6

Metabolon, Inc. Pipeline Products and Clinical Trials Overview 7

Metabolon, Inc.-Pipeline Analysis Overview 9

Key Facts 9

Metabolon, Inc.-Major Products and Services 10

Metabolon, Inc. Pipeline Products by Development Stage 11

Metabolon, Inc. Pipeline Products Overview 13

accuGFR Test 13

accuGFR Test Product Overview 13

ALStarT Diagnostic Test 14

ALStarT Diagnostic Test Product Overview 14

Bladder Cancer Detection Test 15

Bladder Cancer Detection Test Product Overview 15

Bladder Cancer Occult Metastasis Detection Test 16

Bladder Cancer Occult Metastasis Detection Test Product Overview 16

Cisplatin Tolerance Test 17

Cisplatin Tolerance Test Product Overview 17

Diagnostic Assay-Acrolein-Induced Lung Injury 18

Diagnostic Assay-Acrolein-Induced Lung Injury Product Overview 18

Diagnostic Test- Non-Alcoholic Steatohepatitis 19

Diagnostic Test- Non-Alcoholic Steatohepatitis Product Overview 19

Diagnostic Test-Colorectal Cancer 20

Diagnostic Test-Colorectal Cancer Product Overview 20

Diagnostic Test-Lung Cancer 21

Diagnostic Test-Lung Cancer Product Overview 21

Diagnostic Test-Ovarian Cancer 22

Diagnostic Test-Ovarian Cancer Product Overview 22

Diagnostic Test-Recurrence Of Bladder Cancer 23

Diagnostic Test-Recurrence Of Bladder Cancer Product Overview 23

Prostate Cancer TDM Test 24

Prostate Cancer TDM Test Product Overview 24

Renal Cell Carcinoma Detection Test 25

Renal Cell Carcinoma Detection Test Product Overview 25

Renal Cell Carcinoma Occult Metastasis Detection Test 26

Renal Cell Carcinoma Occult Metastasis Detection Test Product Overview 26

Renal Cell Carcinoma Recurrence Risk Test 27

Renal Cell Carcinoma Recurrence Risk Test Product Overview 27

Vasicar 28

Vasicar Product Overview 28

Metabolon, Inc.-Key Competitors 29

Metabolon, Inc.-Key Employees 30

Metabolon, Inc.-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Metabolon, Inc., Recent Developments 32

Jun 02, 2016: Metabolon to Develop accuGFR Kidney Function Test with Johns Hopkins and Tufts Medical Center 32

Apr 28, 2016: Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease 32

Apr 28, 2016: Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease 33

Dec 07, 2015: Lisa Miller Joins Metabolon as Vice President & General Manager of Precision Medicine 34

Dec 07, 2015: Lisa Miller Joins Metabolon as VP of Precision Medicine 34

Aug 17, 2015: Metabolon and Baylor College of Medicine Show Metabolomics May Play Key Role in Precision Medicine 35

Jul 06, 2015: Darin Leigh Joins Metabolon as Chief Commercial Officer 35

Jun 01, 2015: SCIEX and Metabolon Launch the Lipidyzer Platform for Complete Lipid Analysis 36

Mar 18, 2015: Study Shows Quantose IR Measures Insulin Sensitivity Better Than A1C Test for Prediabetes 36

Jan 20, 2015: Newly Published Results Support Clinical Validity of Quantose IGT Diabetes Test 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

Metabolon, Inc. Pipeline Products by Equipment Type 8

Metabolon, Inc. Pipeline Products by Development Stage 11

List of Tables

Metabolon, Inc. Pipeline Products and Clinical Trials Overview 7

Metabolon, Inc. Pipeline Products by Equipment Type 7

Metabolon, Inc. Pipeline Products by Indication 8

Metabolon, Inc., Key Facts 9

Metabolon, Inc., Major Products and Services 10

Metabolon, Inc. Number of Pipeline Products by Development Stage 11

Metabolon, Inc. Pipeline Products Summary by Development Stage 12

accuGFR Test-Product Status 13

accuGFR Test-Product Description 13

ALStarT Diagnostic Test-Product Status 14

ALStarT Diagnostic Test-Product Description 14

Bladder Cancer Detection Test-Product Status 15

Bladder Cancer Detection Test-Product Description 15

Bladder Cancer Occult Metastasis Detection Test-Product Status 16

Bladder Cancer Occult Metastasis Detection Test-Product Description 16

Cisplatin Tolerance Test-Product Status 17

Cisplatin Tolerance Test-Product Description 17

Diagnostic Assay-Acrolein-Induced Lung Injury-Product Status 18

Diagnostic Assay-Acrolein-Induced Lung Injury-Product Description 18

Diagnostic Test- Non-Alcoholic Steatohepatitis-Product Status 19

Diagnostic Test- Non-Alcoholic Steatohepatitis-Product Description 19

Diagnostic Test-Colorectal Cancer-Product Status 20

Diagnostic Test-Colorectal Cancer-Product Description 20

Diagnostic Test-Lung Cancer-Product Status 21

Diagnostic Test-Lung Cancer-Product Description 21

Diagnostic Test-Ovarian Cancer-Product Status 22

Diagnostic Test-Ovarian Cancer-Product Description 22

Diagnostic Test-Recurrence Of Bladder Cancer-Product Status 23

Diagnostic Test-Recurrence Of Bladder Cancer-Product Description 23

Prostate Cancer TDM Test-Product Status 24

Prostate Cancer TDM Test-Product Description 24

Renal Cell Carcinoma Detection Test-Product Status 25

Renal Cell Carcinoma Detection Test-Product Description 25

Renal Cell Carcinoma Occult Metastasis Detection Test-Product Status 26

Renal Cell Carcinoma Occult Metastasis Detection Test-Product Description 26

Renal Cell Carcinoma Recurrence Risk Test-Product Status 27

Renal Cell Carcinoma Recurrence Risk Test-Product Description 27

Vasicar-Product Status 28

Vasicar-Product Description 28

Metabolon, Inc., Key Employees 30

Metabolon, Inc., Other Locations 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Metabolon, Inc., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com